-
1Academic Journal
Authors: Giuliana Papoff, Dario Presutti, Valentina Fustaino, Andrea Parente, Clelia Calandriello, Stefano Alemà, Ferdinando Scavizzi, Marcello Raspa, Giuseppe Merlino, Massimiliano Salerno, Mario Bigioni, Monica Binaschi, Giovina Ruberti
Source: Frontiers in Oncology, Vol 13 (2023)
Subject Terms: NSCLC, PI3K inhibitor, EGFR-TKIs, drug-resistance, combination therapy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
File Description: electronic resource
-
2Academic Journal
Authors: Eugenio Gaudio, Chiara Tarantelli, Filippo Spriano, Francesca Guidetti, Giulio Sartori, Roberta Bordone, Alberto J. Arribas, Luciano Cascione, Mario Bigioni, Giuseppe Merlino, Alessio Fiascarelli, Alessandro Bressan, Afua Adjeiwaa Mensah, Gaetanina Golino, Renzo Lucchini, Elena Bernasconi, Davide Rossi, Emanuele Zucca, Georg Stussi, Anastasios Stathis, Robert S. Boyd, Rachel L. Dusek, Arnima Bisht, Nickolas Attanasio, Christian Rohlff, Andrea Pellacani, Monica Binaschi, Francesco Bertoni
Source: Haematologica, Vol 105, Iss 11 (2020)
Subject Terms: Diseases of the blood and blood-forming organs, RC633-647.5
File Description: electronic resource
-
3Academic Journal
Authors: Tommaso Colangelo, Alessandra Fucci, Carolina Votino, Lina Sabatino, Massimo Pancione, Carmelo Laudanna, Monica Binaschi, Mario Bigioni, Carlo Alberto Maggi, Domenico Parente, Nicola Forte, Vittorio Colantuoni
Source: Neoplasia: An International Journal for Oncology Research, Vol 15, Iss 9, Pp 1086-1099 (2013)
File Description: electronic resource
Relation: http://www.sciencedirect.com/science/article/pii/S147655861380019X; https://doaj.org/toc/1476-5586; https://doaj.org/toc/1522-8002
-
4Academic Journal
Authors: Mario Bigioni
Source: Anti-Cancer Drugs; Nov2005, Vol. 16 Issue 10, p1083-1089, 7p
-
5Academic Journal
Source: International Journal of Cancer; 1/20/2004, Vol. 108 Issue 3, p390-398, 9p
Subject Terms: TUMOR necrosis factors, T cells, ANTIGENS